| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Biochemistry and Molecular Biology, College of Medicine, University of South Florida, Tampa, Florida 33612
Regulation of the expression of hepatic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase by the major end product of the biosynthetic pathway, cholesterol, and by various hormones is critical to maintaining constant serum and tissue cholesterol levels in the face of an ever-changing external environment. The ability to downregulate this enzyme provides a means to buffer the body against the serum cholesterol–raising action of dietary cholesterol. The higher the basal expression of hepatic HMG-CoA reductase, the greater the "cholesterol buffering capacity" and the greater the resistance to dietary cholesterol. This review focuses on the mechanisms of feedback and hormonal regulation of HMG-CoA reductase in intact animals rather than in cultured cells and presents the evidence that leads to the proposal that regulation of hepatic HMG-CoA reductase acts as a cholesterol buffer. Recent studies with animals have shown that feedback regulation of hepatic HMG-CoA reductase occurs at the level of translation in addition to transcription. The translational efficiency of HMG-CoA reductase mRNA is diminished through the action of dietary cholesterol. Oxylanosterols appear to be involved in this translational regulation. Feedback regulation by dietary cholesterol does not appear to involve changes in the state of phosphorylation of hepatic HMG-CoA reductase or in the rate of degradation of this enzyme. Several hormones act to alter the expression of hepatic HMG-CoA reductase in animals. These include insulin, glucagon, glucocorticoids, thyroid hormone and estrogen. Insulin stimulates HMG-CoA reductase activity likely by increasing the rate of transcription, whereas glucagon acts by opposing this effect. Hepatic HMG-CoA reductase activity undergoes a significant diurnal variation due to changes in the level of immunoreactive protein primarily mediated by changes in insulin and glucagon levels. Thyroid hormone increases hepatic HMG-CoA reductase levels by acting to increase both transcription and stability of the mRNA. Glucocorticoids act to decrease hepatic HMG-CoA reductase expression by destabilizing reductase mRNA. Estrogen acts to increase hepatic HMG-CoA reductase activity primarily by stabilizing the mRNA. Deficiencies in those hormones that act to increase hepatic HMG-CoA reductase gene expression lead to elevations in serum cholesterol levels. High basal expression of hepatic HMG-CoA reductase, whether due to genetic or hormonal factors, appears to result in greater cholesterol buffering capacity and thus increased resistance to dietary cholesterol.
This article has been cited by other articles:
|
|
 |
|
  W. R. Lagor, R. Heller, E. D. De Groh, and G. C. Ness Functional Analysis of the Hepatic HMG-CoA Reductase Promoter by In Vivo Electroporation Experimental Biology and Medicine, March 1, 2007; 232(3): 353 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. O. Ward, D. A. Delker, S. D. Hester, S.-F. Thai, D. C. Wolf, J. W. Allen, and S. Nesnow Transcriptional Profiles in Liver from Mice Treated with Hepatotumorigenic and Nonhepatotumorigenic Triazole Conazole Fungicides: Propiconazole, Triadimefon, and Myclobutanil Toxicol Pathol, December 1, 2006; 34(7): 863 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Ness, R. C. Holland, and D. Lopez Selective Compensatory Induction of Hepatic HMG-CoA Reductase in Response to Inhibition of Cholesterol Absorption. Experimental Biology and Medicine, May 1, 2006; 231(5): 559 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hashimoto, R. N. Cohen, M. Yamada, K. R. Markan, T. Monden, T. Satoh, M. Mori, and F. E. Wondisford Cross-talk between Thyroid Hormone Receptor and Liver X Receptor Regulatory Pathways Is Revealed in a Thyroid Hormone Resistance Mouse Model J. Biol. Chem., January 6, 2006; 281(1): 295 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Lagor, E. D. de Groh, and G. C. Ness Diabetes Alters the Occupancy of the Hepatic 3-Hydroxy-3-methylglutaryl-CoA Reductase Promoter J. Biol. Chem., November 4, 2005; 280(44): 36601 - 36608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Johansson, M. Rudling, T. S. Scanlan, T. Lundasen, P. Webb, J. Baxter, B. Angelin, and P. Parini Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice PNAS, July 19, 2005; 102(29): 10297 - 10302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Hapon, S. M. Varas, G. A. Jahn, and M. S. Gimenez Effects of hypothyroidism on mammary and liver lipid metabolism in virgin and late-pregnant rats J. Lipid Res., June 1, 2005; 46(6): 1320 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Oishi, N. Amagai, H. Shirai, K. Kadota, N. Ohkura, and N. Ishida Genome-wide Expression Analysis Reveals 100 Adrenal Gland-dependent Circadian Genes in the Mouse Liver DNA Res, January 1, 2005; 12(3): 191 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Ness and K. R. Gertz Increased Sensitivity to Dietary Cholesterol in Diabetic and Hypothyroid Rats Associated with Low Levels of Hepatic HMG-CoA Reductase Expression Experimental Biology and Medicine, May 1, 2004; 229(5): 407 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Ness and K. R. Gertz Hepatic HMG-CoA Reductase Expression and Resistance to Dietary Cholesterol Experimental Biology and Medicine, May 1, 2004; 229(5): 412 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kisilevsky and S. P. Tam Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1 J. Lipid Res., December 1, 2003; 44(12): 2257 - 2269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xu, L. Lecanu, Z. Han, Z. Yao, J. Greeson, and V. Papadopoulos Inhibition of Adrenal Cortical Steroid Formation by Procaine Is Mediated by Reduction of the cAMP-Induced 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Messenger Ribonucleic Acid Levels J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1148 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Burgess, J. Boucher, T. A-M. Neville, P. Rouillard, C. Stamler, S. Zachariah, and D. L. Sparks Phosphatidylinositol promotes cholesterol transport and excretion J. Lipid Res., July 1, 2003; 44(7): 1355 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. Gober, M. Kistowska, L. Angman, P. Jeno, L. Mori, and G. De Libero Human T Cell Receptor {gamma}{delta} Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells J. Exp. Med., January 20, 2003; 197(2): 163 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Cazita, J. A. Berti, C. Aoki, M. Gidlund, L. M. Harada, V. S. Nunes, E. C. R. Quintao, and H. C. F. Oliveira Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice J. Lipid Res., January 1, 2003; 44(1): 33 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Liu and Y.-Y. Yeh S-Alk(en)yl Cysteines of Garlic Inhibit Cholesterol Synthesis by Deactivating HMG-CoA Reductase in Cultured Rat Hepatocytes J. Nutr., June 1, 2002; 132(6): 1129 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Tacer, T. B. Haugen, M. Baltsen, N. Debeljak, and D. Rozman Tissue-specific transcriptional regulation of the cholesterol biosynthetic pathway leads to accumulation of testis meiosis-activating sterol (T-MAS) J. Lipid Res., January 1, 2002; 43(1): 82 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. L. Bakker, J. C. ter Maaten, C. Popp-Snijders, J. P. J. Slaets, R. J. Heine, and R. O. B. Gans The Relationship between Thyrotropin and Low Density Lipoprotein Cholesterol Is Modified by Insulin Sensitivity in Healthy Euthyroid Subjects J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1206 - 1211. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
